Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 11—November 2015
Dispatch

Economic Costs of Measles Outbreak in the Netherlands, 2013–2014

Anita W.M. SuijkerbuijkComments to Author , Tom Woudenberg, Susan J.M. Hahné, Laura Nic Lochlainn, Hester E. de Melker, Wilhelmina L.M. Ruijs, and Anna K. Lugnér
Author affiliations: National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands (A.W.M. Suijkerbuijk, T. Woudenberg, S.J.M. Hahné, L. Nic Lochlainn, H.E. de Melker, W.L.M. Ruijs, A.K. Lugnér); European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, Stockholm, Sweden (L. Nic Lochlainn)

Main Article

Table 2

Distribution of costs of measles outbreak, the Netherlands, 2013–2014*

Category Costs, $ % of total costs
MHS 1,852,470 39.5
Hospitalization 852,567 18.2
RIVM 698,280 14.9
Production losses 365,885 7.8
Laboratory tests 358,801 7.6
Vaccination of children 299,840 6.4
Vaccination of health care workers 222,203 4.7
General practitioner consultation
 44,350
 0.9
Total 4,694,395 100

*Costs are calculated in 2013 US dollars ($). Total cost differs slightly from sum of category costs because of rounding. MHS, municipal public health services; RIVM, National Institute for Public Health and the Environment, the Netherlands.

Main Article

Page created: November 16, 2015
Page updated: November 16, 2015
Page reviewed: November 16, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external